Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating, Announces Target Price $34
Stifel Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $40
A Quick Look at Today's Ratings for OrthoPediatrics(KIDS.US), With a Forecast Between $34 to $50
OrthoPediatrics (KIDS) Initiated With a Hold at Truist Financial
OrthoPediatrics Analyst Ratings
Buy Rating Reaffirmed for OrthoPediatrics on Robust Growth Strategy and Strong Financials
BTIG Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $44
Piper Sandler Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Raises Target Price to $44
Piper Sandler Reaffirms Their Buy Rating on OrthoPediatrics (KIDS)
OrthoPediatrics Analyst Ratings
Truist Securities Reiterates Hold on OrthoPediatrics, Lowers Price Target to $30
JMP Securities Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $50
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating
JMP Securities Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $50
OrthoPediatrics Outperforms With Strong Growth and Strategic Expansion: A Buy Rating Insight
OrthoPediatrics Analyst Ratings
Truist Trims Price Target on OrthoPediatrics to $35 From $38, Maintains Hold Rating
Truist Securities Maintains Hold on OrthoPediatrics, Raises Price Target to $38
Truist Securities Raises Price Target on OrthoPediatrics to $38 From $35, Maintains Hold Rating
OrthoPediatrics Analyst Ratings
No Data
No Data